CRL vs NATL · rev $2.00B vs P/E 19, rev $1.15B
Charles River Laboratories (CRL) versus NCR Atleos Corporation (NATL) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
NCR Atleos Corporation (NATL) is a software - application company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported NATL revenue for 2025-12-31 was $1.15B. Net income was $83.0M. Revenue was up 4.0% from 2024-12-31 to 2025-12-31. NATL currently screens at market cap $2.17B and trailing P/E 18.8.
CRL currently screens at market cap $7.78B. NATL currently screens at market cap $2.17B and trailing P/E 18.8.
Not investment advice. Open the CRL and NATL stock pages for the full models.
Not investment advice.